Multicenter validation of CEACAM6 and FOXP3 as robust prognostic biomarkers in colon cancer: Combined immunohistochemical and transcriptomic analysis.

Saved in:
Bibliographic Details
Title: Multicenter validation of CEACAM6 and FOXP3 as robust prognostic biomarkers in colon cancer: Combined immunohistochemical and transcriptomic analysis.
Authors: Liu, Yingying1 (AUTHOR), Ye, Jianxin2 (AUTHOR), Ma, Jinzhao3 (AUTHOR), Pan, Xingxiao4 (AUTHOR) 15251573770@163.com
Source: Molecular & Clinical Oncology. Dec2025, Vol. 23 Issue 6, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20499450
DOI:10.3892/mco.2025.2897